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Abstract: The efficacy of pomegranate (Punica granatum) extract (PE) for improving performance
and post-exercise recovery in an active population was equivocal in previous studies. In this study,
a randomised, double-blinded, placebo-controlled, balanced, cross-over trial with two arms was
conducted. Eligibility criteria for participants were as follows: male, amateur cyclist, with a training
routine of 2 to 4 sessions per week (at least one hour per session). The cyclists (n = 26) were
divided into treatment (PE) and placebo (PLA) groups for a period of 15 days. After physical tests,
the groups were exchanged after a 14-day washout period. Exercise tests consisted of endurance
bouts (square-wave endurance exercise test followed by an incremental exercise test to exhaustion)
and an eccentric exercise drill. The objective was to assess the efficacy of PE in performance outcomes
and post-exercise muscular recovery and force restoration after a prolonged submaximal effort.
Twenty-six participants were included for statistical analysis. There was a statistically significant
difference in total time to exhaustion (TTE)(17.66–170.94 s, p < 0.02) and the time to reach ventilatory
threshold 2 (VT2)(26.98–82.55 s, p < 0.001), with greater values for the PE compared to the PLA group.
No significant results were obtained for force restoration in the isokinetic unilateral low limb test.
PE, after a prolonged submaximal effort, may be effective in improving performance outcomes at
maximal effort and might help to restore force in the damaged muscles.
Keywords: pomegranate; exercise performance; sports nutrition; delayed onset muscle soreness;
muscle recovery; antioxidants
1. Introduction
Polyphenols are natural occurring antioxidants and represent one of the most numerous and
widely distributed groups of substances in the plant kingdom; as much as 8000 phenolic structures
are currently categorized into four groups (flavonoids, stilbenes, lignans and phenolic acids) [1].
Polyphenols are widely found in foods including wine, green tea and red-coloured fruits such as
pomegranate [2,3]. Some clinical intervention studies support the hypothesis of some cardiovascular
benefits arising from polyphenol-rich beverages (red wine, tea and cocoa) [4,5]. In fact, epidemiological
evidence suggests that polyphenols, at least in part, might explain the cardiovascular benefits from
increased fruit and vegetable intake [6].
The pomegranate fruit includes bioactive substances such as hydrolysable tannins (gallotannins
and ellagitannins), ellagic acid and its derivatives, gallic acid, anthocyanins/anthocyanidins,
proanthocyanidins, flavonoids, vitamins, as well as sterols, lignans, saccharides, fatty acids, organic
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acids, terpenes and terpenoids, among others [7]. A study on different varieties of pomegranate
showed that their total polyphenol content (TPC) and antioxidant activity vary depending on the part
used and cultivar [8,9]; the TPC can be 20 times higher in the whole fruit than in arils [10]. Pomegranate
juice is a source of polyphenols such as anthocyanins, flavanols and some ellagitannins (especially
punicalagin), revealing a potent antioxidant activity that is three times higher than the well-known
antioxidant properties of red wine or green tea [11].
The most abundant of these polyphenols in pomegranate juice is punicalagin [12], belonging to
the ellagitannin subgroup (hydrolysable tannins), implicated as the bioactive constituent responsible
for more than 50% of the juice’s potent antioxidant activity [13] but the content of polyphenols in
commercial pomegranate juices varies according to variety and industrial manufacturing process
with considerable variability in the punicalagin content [11]. It seems that most of the studies carried
out with pomegranate extracts were juices with a high polyphenol content without a standardized
punicallangin content.
Pomegranate juice has shown many beneficial effects on markers of cardiovascular health
including: A)Blood pressure: Systolic blood pressure (SBP) and diastolic blood pressure (DBP)
lowering, as showed in a meta-analysis (n = 322) expressed as the weighed mean difference (WMD)
[SBP (WMD: −4.96 mmHg, 95% CI: −7.67 to −2.25, p < 0.001) and DBP (WMD: −2.01 mmHg,
95% CI: −3.71 to −0.31, p = 0.021)] [14]; and through decreased activity of related enzymes: serum
angiotensin-converting enzyme (36% decrease) [15]; and possibly 11β-hydroxysteroid dehydrogenase
type 1 enzyme activity [16]. B)Improved lipid metabolism: by a diminished low-density lipoproteins
aggregation and an increased serum paraoxonase activity up to 20% [17] (an enzyme possessing
atheroprotective properties [18]); and decreased glucose conversion to fat (by inhibition of basal
glucose incorporation into lipids in human adipocytes [19]). C)Reduced markers of oxidative stress:
by diminished lipid peroxidation in overweighed and obese humans after physical exercise [20] and
against smoking (in rats), also showing increased levels of antioxidant enzymes [21].
In sport, polyphenols exert physiological effects that can increase by 1.90% [95% confidence
interval (CI) 0.40–3.39] a diversity of athletic performance parameters – such as exercise time to fatigue,
distance covered in a pre-selected time period, time to complete a certain distance and maximum
power output – in both untrained but predominantly trained males [22]. Moreover, there are a
number of both narrative and systematic reviews supporting the role of polyphenol supplementation
in endurance performance [23–26] showing decreased rate of perceived exertion (RPE), increased
maximal oxygen uptake and a faster recovery of muscle capacity (with a parallel trend to a faster
decrease of inflammatory markers [27]).
Polyphenols have been purported to improve aerobic metabolism through stimulation of
mitochondrial biogenesis (by increasing expression of genes encoding cytoprotective proteins [28] and
activation of sirtuins [29] mediated by specific polyphenols such as catechins, resveratrol, quercetin
and curcumin [30]). On the other hand, antioxidant supplementation may impair muscle performance
by decreasing force production (by blocking oxygen delivery from blood to myocytes [31] and by
modifying basal cellular redox state [32]) and training adaptations derived from physical stress [23–26].
The purpose of this study was (1) to test the hypothesis that pomegranate extract (PE), in dietary
doses, can benefit endurance capacity (sub-maximal and maximal) after an extenuating bout and (2) the
contribution of PE to post-exercise strength recovery after an exercise induced muscular damage.
2. Materials and Methods
2.1. Subjects
Thirty amateur endurance-trained male athletes (age: 34.9 ± 10.0 years; weight: 74.8 ± 11.3 kg;
height: 1.75 ± 0.05 m; body mass index (BMI): 24.5 ± 3.0 kg/m2; maximal oxygen consumption
(VO2max): 54.4 ± 9.0 mL/min/kg) volunteered to participate in the study. Inclusion criteria were as
follows: (1) male aged between 18–55 years old; (2) amateur cyclist, with a training routine of 2 to 4
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sessions per week, for at least one hour per session. Exclusion criteria were as follows: (1) allergy to
pomegranate or any of its by-products; (2) serious clinical pathology or antecedents; (3) regular smoker;
and (4) supplementation with ergogenic aids in the last 3 months. Participants were informed (verbally
and written) of the purpose of this study, the characteristics of the product used for supplementation,
its effects, as well as any possible risk and side effects resulting from the supplement and the procedures
of the study. Subject were informed of their right to quit the study at any time, without the need to
provide any reason. Participants gave written consent before the study was started. The study protocol
and informed consent were approved by the Ethics Committee of the Catholic University of Murcia
(UCAM) and were in agreement with the Declaration of Helsinki.
2.2. Trial Design
A double-blind, placebo-controlled, randomised, balanced, crossover design with two different
study arms was used to test the effect of pomegranate extract (PE) or placebo (PLA) supplementation.
Randomization was performed by a scientist not participating in the study, using software (Epidat 4.2,
2016) that generated random codes which were assigned to participants. An initial incremental exercise
test to exhaustion (IETE) was carried out to make an initial assessment of the physical condition of each
participant. Then, supplementation protocol of each group (PE or PLA) commenced (first allocation
round), for a period of 15 days, after which cyclists underwent the exercise protocol (endurance and
strength) to measure intervention effect. Afterwards, supplementation was discontinued 14 days for
washout and the same procedure was repeated in the second allocation round (crossover design).
2.3. Supplementation Protocol
Participants ingested two capsules of PE (composition per capsule: 375 mg of POMANOX® P30
with 30% punicalagins; total amount of punicalagins α + β per capsule: 112.5 mg) per day, immediately
after breakfast; that is, a total dose of 225 mg punicalagins/day, for 15 days of treatment per study arm
(or PLA (placebo): 15 days/15 days of experimental product), with 14 days of washout between them.
Both products, PE (POMANOX® P30, EUROMED S.A., Barcelona, Spain) and PLA (maltodextrin)
were identical in appearance: hard, orange-coloured capsules sealed in a 15-capsule aluminium blister
pack, inside a cardboard box (3 blisters per box), properly labelled, randomized and identified. Storage
instructions stated to store the product in a cool dry place, away from sunlight and intense odours.
Identification and quantification tests of the final product were performed by high-performance
liquid chromatography (HPLC) according to the supplier reference standard, by a validated method
of analysis (SOP No. HPLC-757). Compliance with the identification and quantification of the active
ingredient, providing at least 30% of punicalagins α + β, was checked with the certificate of analysis
provided by the manufacturer to ensure proper final product specifications.
2.3.1. Compliance and Follow-Up
To ensure compliance and fulfilment, participants were given an extra blister pack provided as a
backup (in case of accidental loss) and were asked to return empty blister packs and spare capsules
after each intervention.
For the follow-up, participants were reminded verbally and through e-mail communication to
consume the experimental supplements.
2.3.2. Dietary Assessment and Control
The dietary habits of the participants were recorded using a validated food questionnaire. Subjects
did not change their usual diet during the study period. On the day before and the same day as any
performance test, volunteers had to comply with a previously detailed diet developed by a nutritionist,
until the test was performed. This included refraining from taking caffeine and any other ergogenic
aids or drugs that could affect performance measures. This measure was taken to ensure that the
observations made were only due to the supplement and were not influenced by other modifications in
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the diet. Additionally, volunteers were asked for their meal intake when they arrived at the laboratory
to check diet compliance. Any variation in diet was written in a control table by the nutritionist to
keep track of diet modifications.
2.4. Exercise Tests
At every supplementation completion, a square-wave endurance exercise test (SWEET), followed
by an IETE and a subsequent eccentric exercise drill were performed.
The purpose of the first two tests (endurance tests) was to assess performance outcomes.
The purpose of the eccentric protocol was to evoke exercise induced muscle damage (EIMD) to
assess the contribution of the supplement to post-exercise biomarkers; therefore, no performance data
were collected for this drill.
All three tests were conducted sequentially in the same session after each allocation round,
separated by a 29-day lapse (14 days for washout and 15 days in the other crossover supplementation
arm). Athletes did not change their physical activity habits during the study and were told to avoid
physical exercise the day before they performed the tests.
Environmental conditions (room temperature and humidity) were replicated in every exercise test
for optimal conditions using room air conditioning system and were additionally measured during
the tests.
2.4.1. Initial Physical Assessment: Aerobic and Health Assessment
A preliminary IETE test was performed to assess the training status of volunteers at baseline,
7 days prior to commencement of the exercise tests. The purposes of this test were to (1) familiarize
volunteers with the testing procedures and subjective feelings of the exercise tests; (2) determine
submaximal external workload for each of the exercise tests (set at 60% and 70% of the VO2max);
and (3) establish ventilatory thresholds of participants (corresponding the anaerobic ventilatory
threshold to the ventilatory threshold 2 (VT2)).
Every participant used their own bicycle placed on the rear wheel, so repeatability was controlled
by this corrective measures: 1)Front–rear slope-ratio was corrected to zero (using a front wheel riser)
during the trial; 2)Bike configuration (gear set, saddle and handlebars) should be kept during the
study; 3)Bike fitting (seat-post height and angle, handlebar reach, height and grip position) should
be the same and; 4)Preferred pedalling system (use of cycling shoes and type of clip/cleat) should
be consistent.
Test consisted of a 3-min warm-up at a self-paced intensity, followed by an IETE (initial load:
50 Watts (W), with a 35-W step increment every minute) on an electronically braked cycle ergometer
(Cyclus2, RBM elektronik-automation GmbH, Leipzig, Germany) at a self-selected cadence between
60–100 revolutions per minute (RPM) on a fixed gear selected at the beginning of the test. Volunteers
were verbally encouraged by the staff to exert maximal effort. Exhaustion was deemed to occur
when the subject decided to stop, when pedal cadence dropped 20 RPM below the minimum cadence
established (i.e., 40 RPM) or when power output could not be maintained.
Heart rate was monitored continuously using an electrocardiograph and oxygen consumption
(VO2) was collected continuously during this test using an automated breath-by-breath system (Jaeger
Oxycon ProTM, CareFusion, Höchberg, Germany) calibrated before each test. All measures were
analysed using software (LABManager 5.3.0.4, VIASYS Healthcare GmbH, Höchberg, Germany) and
were stored in a personal computer for later recall. Maximal criteria were interpreted according to [33],
defined as a plateau of VO2, respiratory quotient (RQ) above 1.10 and heart rate (HR) above 95% of the
theoretical maximum HR.
Ventilatory aerobic and anaerobic threshold were plotted in a graph by using previously
mentioned software and interpreted according to the three-phase model [34] by ventilatory equivalents
(VE) [35]. VT2 was set as the intersection point between the carbon dioxide ventilatory equivalent
(VE/VCO2) and the oxygen ventilatory equivalent (VE/VO2) against time - defined as the point in
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which pulmonary ventilation during exercise (VE) starts to increase at a faster rate than oxygen uptake
(VO2). Time values to reach VT2 were provided by the same software when a vertical line was placed
on this intersection point.
After completion of the initial IETE, subjects were familiarized with the eccentric drill and
isokinetic test.
2.4.2. Exercise Tests: Endurance Test and Strength Protocol
Once the supplementation protocol was completed, sets of different exercise tests were performed
on the same day, which are summarised as follows:
1. Endurance test
a. Square-wave endurance exercise test (SWEET), followed immediately by
b. Incremental exercise test to exhaustion (IETE), followed by 5 min of rest.
2. Strength protocol
c. Eccentric exercise drill.
Endurance Tests (SWEET and IETE)
a. Square-wave endurance exercise test (SWEET): A constant intensity cycling test was performed
on the same electronically braked ergometer in same conditions. Subjects were instructed to
complete a self-paced 10-min warm-up, without reaching initial load, followed by 90 min of
SWEET with an individual load in watts, corresponding to 70% of VO2max as calculated after
a preliminary test. HR was continuously monitored using a pulsometer (Polar RS800CX, Polar
Electro Oy, Finland) to double-check that athletes remained under VT2 at the given intensity,
by screening the heart rate variability which showed significant correlation with VT2 in previous
work [36]. To ensure proper performance, cyclists followed a hydration protocol, which was
measured during the trial [37]. Subjects were asked to estimate their rate of perceived exertion
(RPE) using the Borg scale [38] (scale from 1 to 20) after warm-up (10 min after commencement)
and after 30, 50, 70 and 90 min (end of the test).
b. Incremental exercise test to exhaustion (IETE): Once the SWEET was completed, the maximal
incremental cycling test was performed without interruption. Following 3 min of recovery at a
self-selected intensity (never above the initial load), subjects performed a progressive incremental
cycling test (initial load: 60% of VO2max) with the same equipment and conditions as the
preliminary test. The difference now was that every step consisted of 3 min instead of one
(i.e.,: 35-W increase every 3 min). Lactate samples were collected 1 min 40 s after completing the
test by lancing the left ring-finger pad and were immediately analysed by a blood gas analyser
(ABL90FLEX, Radiometer Medical APS, Copenhagen, Denmark). Subjects were then asked again
to estimate their RPE.
Strength Protocol (Eccentric Drill)
c. Subjects were given 5 min of transition time before performing the eccentric exercise test in
another room with same conditions. The whole drill consisted of 15 repetitions, for a total of
6 sets per leg (15 × 6 = 90 repetitions per leg) performed at a specific cadence (1:4). The exercise
sequence is depicted in Scheme 1.
A single-leg barbell step-up onto a bench, with no load and locked upper body (straight spine),
was employed as described in Reference [39]. Subjects were given a plastic tube (200 cm long), which
they had to place resting on their shoulders behind their head (with prone grip), forming a 45◦ angle
between the forearm and arm. A fitness bench was placed in front of them, creating a 90◦ angle
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between the thigh and lower leg of the raised leg. Individual angles were measured by a goniometer
prior to test, for bench height positioning. Subjects had to extend the leg placed on the bench, settling
the other leg next to it (finishing the movement with both legs together and both knees extended)
in 1 s, while reverting to initial position had to be completed in 4 s (consisting the full sequence of
5 s). Cadence compliance was facilitated by playing a free metronome app (Mobile Metronome 1.2.4F
(2012), Gabriel Simoes, Google Play-Google LLC) at a speed of 60 beats per minute (bpm) in a 5/4
measure (with a different sound for the first beat of every measure) corresponding every beat to 1 s.
One researcher supervised proper positioning and cadence of subjects during the drill.
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Scheme 1. Eccentric exercise drill. The first picture (a) represents the initial position while (b) is the end
position. The first sequence of the exercise consisted of moving from (a) to (b) and had to be performed
in 1 s. Then, the initial position had to be recovered within 4 additional seconds. Both movements were
considered to be 1 repetition. Pictures by © Everkinetic/http://everkinetic.com/, from the Wikimedia
Commons project and distributed under a CC-BY-SA-3.0 license.
2.5. Variables and Measurements
The following variables ere e I itial physical a se sment (IETE): Total time to
exhaustion (T E), oxygen consu pti ( 2 s ption (VO2max).
Endurance tests: t t i t it rance test (S EET): Rate of perceived exertion (RPE).
Maximal test (I ): , ti e to reach VT2 (time to VT2), VO2max, oxygen consumption at VT2
(VO2 at VT2) and lactate blood concentration (mmol/L) at the end of the test.
Post-exercise force recovery was easured by an isokinetic unilateral leg test (with the dominant
limb) performed 2, 24, 48 and 72 h after the axi al IETE by a specially designed device (SYSTEM 3
PRO, Biodex Medical Systems Inc., Shirley, NY, USA) consisting of a dynamometer, chair and belts.
Subjects had to perform maximal force output during a fixed angular velocity (60◦ per second) for
both knee flexion and extension. The isokinetic variables measured were: Peak torque (N × m/Kg),
relative work (J/Kg), work fatigue (%) and average power (W).
Evolution of muscular damage and inflammation biomarkers (creatine kinase (CK) and C-reactive
protein (CRP), respectively) were measured by blood collection, 10 min before the first isokinetic test
and subsequently upon each strength assessment completion (2, 24, 48 and 72 h later). Samples were
divided and placed in vacuum tubes for either freezing or centrifugation and were immediately sent
for laboratory analysis performed by an automatic analyser (IL Ilab 600, Chema diagnostica, Monsano
AN, Italy).
A summary of the experimental design is depicted in Scheme 2.
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2.6. Statistical Analysis
Quantitative variables are described as the mean, standard deviation and 95% confidence interval.
This description was made for the total sample and was stratified by the randomized treatment arm.
Qualitative variables are presented in tabular form, including the relative and absolute frequencies
for the treatment groups and the global sample. Data were checked prior to analysis; in all cases,
the Kolmogorov–Smirnov test was applied to test for a normal distribution and Levene’s test was used
to test for homoscedasticity.
The evolution of these quantitative variables was analysed by parametric tests: a repeated
measures t-test for the obtained variables from the IETE endurance exercise test and a two-way
repeated measures ANOVA test with one within-subject factor (product) and one between-subject
factor (time) for the variables obtained in the SWEET endurance exercise test and from the strength
protocol. For the post hoc group comparison, the Bonferroni test was employed.
Statistical analysis was performed using SPSS software (version 21.0, Chicago, IL, USA) and
p values are reported for every group and group × time interaction; p < 0.05 is considered
statistically significant.
3. Results
3.1. Participant Flow Diagram and Baseline Characteristics
The participant flow diagram is depicted in Figure 1.
A total of 37 subjects were initially recruited, of which seven were excluded due to non-compliance
with the inclusion criteria (n = 5) or unwillingness to participate (n = 2). Thirty subjects met the initial
screening criteria and were randomized. During the study, four of them (two from each arm) dropped
out because of poor adherence to supplementation protocol. Finally, 26 subjects (13 subjects in each
arm) received treatment successfully and were included for statistical analysis. All participants were
cyclists competing at the regional level (Region of Murcia, Spain). The descriptive analysis at baseline
is summarized in Table 1.
No significant differences were found for intra-subject values in any of the studied measures
before each allocation. Therefore, we assumed that: (1) Participants started each intervention in same
conditions; (2) Washout was successful in restoring values to baseline.
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i . Participant flow diagram of the crossover design. Every group rec ived both treatments
(15 days of supplementation) separated by 14 days of washout.
Table 1. Baseline demographic and clinical characteristics of participants. Values are presented as the
mean with standard deviation (SD).
(n = 26) Mean SD
Weight (Kg) 74.8 11.3
Height (m) 1.75 0.05
Body ass index (Kg/m2) 24.5 3.0
Age (years) 34.9 10.0
Systolic blood pressure (mm Hg) 129.8 11.9
Diastolic blood pressure (mm Hg) 77.5 9.0
VO2 max (mL/min/Kg) 54.4 9.0
VO2 in VT2 1 (mL/min/Kg) 41.6 8.5
1 Ventilatory threshold 2.
3.2. Conditions during Exercise Tests
No statistical difference w s found for any of the measures in any group for temperature
(p = 0.52), relative humidity (p = 0.97) or hydration (p = 0.77). During the PE tests, temperature
was 22.12 ± 1.56 ◦C with a relative humidity of 57 ± 0.94%, whereas PLA temperature and relative
humidity were 22.31 ± 1.57 ◦C and 57 ± 0.96%, respectively. Average water consumption was
1171.7 ± 304.8 mL for PE and 1156.3 ± 295.8 mL for PLA. Therefore, we assumed homogeneity of
conditions among the performance trials for both groups.
3.3. RPE during and after the Square-Wave Test (SWEET)
The Borg’s scale results are presented in Table 2.
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Table 2. Rate of perceived exertion (RPE) during the SWEET test. Borg scale (20-number scale), the
lowest value corresponds to the lowest effort perceived and the highest to maximal perceived effort.
Group
RPE during SWEET (90 min)
Time
p-Value
Group× Time
p-Value
after
Warm-Up
End of
Test
Min 10 Min 30 Min 50 Min 70 Min 90
PLA 10.8 ± 2.6 11.9 ± 2.4 12.2 ± 2.3 12.7 ± 2.4 13.2 ± 2.3 < 0.001
0.74
PE 11.0 ± 2.2 12.1 ± 2.4 12.8 ± 2.0 13.2 ± 2.0 13.7 ± 2.3 < 0.001
There was no statistically significant interaction effect between the effects of treatment and time on
perceived effort. There was a statistically significant change in RPE for both groups from the beginning
of the test (after the 10-min warm up), without a statistical inter-group difference. The average RPE
reported for both groups was 13, corresponding in Borg’s scale to “somewhat hard”.
3.4. Incremental Exercise Test to Exhaustion (IETE)
IETE results are shown in Table 3.
Table 3. Total time to exhaustion (TTE), time to reach ventilatory threshold 2 (time to VT2), maximal
oxygen consumption (VO2max), oxygen consumption at ventilatory threshold 2 (VO2 at VT2) and
lactate for the IETE. The difference is presented with a 95% confidence interval (CI).
PLA PE Difference (95% CI) Time p-Value
TTE (sec) 663.05 ± 222.70 757.35 ± 174.91 17.66–170.94 <0.02
Time to VT2 (sec) 533.33 ± 180.15 588.10 ± 154.75 26.98–82.55 <0.001
VO2max (ml/min/Kg) 3957.75 ± 612.71 3871.35 ± 606.34 −257.27–84.47 0.30
VO2 at VT2 (ml/min/Kg) 3471.05 ± 473.87 3453.60 ± 500.27 −123.29–87.99 0.73
Lactate (mmol/L) 8.93 ± 2.43 9.23 ± 2.69 −0.73–1.32 0.55
There was a statistically significant difference in TTE and the time to reach VT2, with greater
values for the PE compared to the PLA group. There was no statistically significant difference for
VO2max, VO2 at VT2 or lactate.
3.5. Strength Protocol: Eccentric Exercise and Isokinetic Force
All subjects completed the eccentric exercise drill successfully. The isokinetic force results are
shown in Table 4.
Table 4. Isokinetic test values are presented as means with standard deviation. All units are presented
in international units (IU); newton (N), meter (m), kilogram (Kg) and joule (J). For peak torque and
work, relative values are given based on the subject’s total weight.
Group
Post-Test Time
p-Value
Group× Time
p-Value2 h 24 h 48 h 72 h
Extension
(60◦· s−1)
Peak Torque
(N×m/Kg)
PLA 250.8 ± 31.4 274.3 ± 37.2 276.6 ± 34.4 274.6 ± 38.6 <0.05
0.38PE 248.3 ± 43.2 267.1 ± 43.2 263.6 ± 63.0 279.4 ± 40.6 <0.01
Relative work (J/Kg) PLA 188.5 ± 32.0 203.9 ± 31.6 200.0 ± 30.3 204.3 ± 32.4 <0.001 0.31PE 185.6 ± 32.0 200.7 ± 33.6 199.0 ± 52.1 215.8 ± 35.5 <0.001
Work fatigue (%) PLA 14.3 ± 11.9 16.4 ± 10.5 16.6 ± 9.1 15.8 ± 8.1 0.81 0.38PE 9.8 ± 10.4 15.6 ± 11.0 14.6 ± 13.7 14.9 ± 13.0 <0.5
Average power (W) PLA 120.7 ± 21.3 141.4 ± 22.8 144.8 ± 23.5 147.0 ± 26.9 <0.001 0.78PE 118.4 ± 32.8 134.2 ± 30.0 138.4 ± 39.5 146.6 ± 27.4 <0.001
Flexion
(60◦· s−1)
Peak Torque
(N×m/Kg)
PLA 132.7 ± 23.7 144.3 ± 28.3 147.7 ± 28.3 145.3 ± 28.1 <0.001
0.14PE 132.9 ± 33.1 134.3 ± 25.7 139.1 ± 38.1 148.9 ± 29.6 <0.01
Relative work (J/Kg) PLA 101.6 ± 20.0 105.9 ± 27.1 104.1 ± 26.2 106.8 ± 22.7 0.34 0.28PE 99.4 ± 21.8 101.3 ± 20.1 103.1 ± 30.9 113.3 ± 22.2 <0.01
Work fatigue (%) PLA 19.1 ± 11.5 22.0 ± 8.0 25.9 ± 8.8 23.1 ± 5.4 0.09 0.98PE 15.5 ± 18.2 16.3 ± 11.0 20.4 ± 9.4 18.9 ± 17.0 0.56
Average power (W) PLA 66.9 ± 15.4 76.3 ± 16.9 77.2 ± 15.2 77.7 ± 17.4 <0.03 0.24PE 62.6 ± 18.5 68.3 ± 14.1 74.5 ± 22.0 79.7 ± 15.4 <0.001
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There was no statistical significance for the group× time values of any of the variables. There were
greater values in PE for peak torque and relative work, both in extension and flexion values at 72 h.
Work fatigue was lower for PE than for PLA, whereas average power was greater for PE in flexion and
for PLA in extension.
3.6. Post-Exercise Muscular Damage and Inflammation
The evolution of muscular markers is presented in Table 5.
Table 5. Creatine kinase (CK) and C-reactive protein (CRP) values at baseline and 2, 24, 48 and 72 h
after physical tests. Data were obtained using a paired two-tailed Student’s t-test. Data are presented
as the mean with SD.
Basal Post-Test Time
p-Value
Group× Time
p-Value0 h 2 h 24 h 48 h 72 h
CK
PLA 119.00 ± 30.87 196.69 ± 126.51 313.94 ± 392.51 234.13 ± 215.20 184.88 ± 122.34 <0.05
0.71PE 114.63 ± 48.51 176.94 ± 101.18 254.06 ± 240.51 208.00 ± 153.81 169.81 ± 113.78 <0.02
CRP
PLA 0.58 ± 0.34 0.57 ± 0.35 2.23 ± 2.12 1.59 ± 2.34 1.06 ± 1.40 <0.001
0.46PE 0.59 ± 0.27 0.60 ± 0.29 1.74 ± 1.08 1.06 ± 0.85 0.80 ± 0.56 <0.001
Baseline conditions were similar for both groups for CK and CRP. There was a significant change
from baseline conditions for both groups for the time value but there was no statistical significance for
CK and CRP between groups. Both CK and CRP were lower for PE than for PLA 72 h after the trial,
especially CRP (27.96% lower than that observed in PLA).
4. Discussion
4.1. Primary Findings
The primary finding from this study was that 14 days of PE supplementation significantly
increased the TTE of trained cyclists and the time to reach VT2 in a maximal test (IETE), after a long
endurance effort (SWEET), compared to a placebo. This means that both maximal and submaximal
performance increased. Previous studies of pomegranate supplementation on exercise performance
and post-exercise recovery were limited and unclear, according to a recent meta-analysis [40]. To the
best of our knowledge, this is the first study that has used a performance protocol combining an IETE
after previous physical attrition in a SWEET to test the performance contribution of PE to performance
outcomes. The physiological conditions of the physical protocol are similar to those occurring in
long-distance competitions, when participants decide to increase their intensity in the last km/miles of
the race, after a long submaximal effort and may be valuable when our aim is peak performance.
4.2. Acute Effect versus Chronic Benefits
Previous studies have observed performance improvements with an acute dosing of PE.
Ellagitannin metabolites (including punicalagins) were previously studied in humans, showing a time
to reach blood peak concentration of 1 h, with a clearance of 5 h for all participants [41,42]. In fact,
ellagitannins are not absorbed as such; they are metabolized by the flora to yield up to 30 derived
metabolites (mainly urolithins) [43]. In the current study, participants consumed the supplement
during the morning, the same day of the tests, with a time lapse greater than 5 h from the test, so any
possible acute ergogenic benefit from PE should be discarded due to an acute dose.
However, results in the current study are in line with a study on active runners, which found
significant increases in TTE at 90% and 100% of peak velocity by a single dose of PE, 30 min before the
trial, when performing a maximal test on a treadmill [44]. By contrast, a study with trained cyclists
during high-intensity cycling in a high-altitude environment reported no overall significant effect from
acute supplementation 2.5 h before the trial [45]. Our study was performed with a larger sample size
(26 subjects instead of 8) and a chronic supplementation plan (15 days), which could have contributed
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to the shifting of the results. Furthermore, the current study seems to have the largest sample size
of elite cyclists (n = 26) testing the supplementation of pomegranate for endurance performance and
post-exercise recovery.
4.3. Pomegranate and Hypothetic Acute Effect through the Nitric oxide Pathway
Some of the acute effects of PE have been attributed to the nitrate content of pomegranate,
which can have a role in nitric oxide (NO) formation during exercise. NO regulates physiological
functions and has been recognized as an important factor in endothelial vascular relaxation during
exercise [46–48] which also increases muscle blood flow [49]. Pomegranate significantly increase plasma
nitrate (NO3) when supplemented for 8 days [50]. In addition, other polyphenol-rich supplements can
produce a similar vasodilatation and contribution to NO pathways [51]. PE’s contribution to nitric
oxide pathways could be due to its polyphenol content, which may protect the already produced nitric
oxide against oxidative destruction, therefore enhancing its biological actions [52]. The current study
administered PE for 15 days, which would be enough to elicit such benefits. However, as a scope
limitation, nitrate concentration was not measured (neither in the product nor plasma as converted
nitric oxide) since neither of these variables was within the scope of this study. Further research in this
field is warranted for a better understanding of PE’s contribution to NO metabolic pathways.
4.4. Role of Pomegranate, Polyphenols and Punicalagins in Exercise Performance
To our knowledge, this is the first clinical trial that has studied the effect of a pomegranate
extract standardized in punicalagins on exercise performance. The pomegranate extract used in this
study is different in characteristics to other pomegranate extracts or juices regarding its polyphenol
(and especially punicalagin) content. This ingredient (POMANOX® P30) is made from whole fruits,
only from Spanish cultivars and with dedicated technology and processing [53] being the only solvent
used in the extraction step purified water, allowing the water-soluble polyphenols of the whole
pomegranate fruit to be obtained.
Food supplements made of natural extracts can have a multifactorial effect, due to a rich variety
of active substances (such as different types of polyphenols, depending on the source [54]), so specific
mechanisms underlying their ergogenic effect are not easily deciphered. On the contrary, isolated
active substances or standardized raw materials allow a more specific metabolic target but may
hamper average supplement’s effect size by synergistic substances naturally present or by other
unclear mechanisms.
As an example, isolated quercetin (a flavonoid from the flavonoid subclass of polyphenols)
has been tested in sport performance without showing improvements [55,56] while the ellagitannin
subclass of polyphenols, representing the majority of polyphenols in PE, has shown an increase in
repeated sprint ability and running time to exhaustion, as well as blood flow and vessel diameter [44,57].
Isolated punicalagins in humans have been shown to have a particular pharmacokinetic effect – they
are not easily converted to ellagic acid (another abundant ellagitannin molecule in pomegranate
extracts) – which is indicative of behaviour different to other ellagitannin molecules [58]. Another
example was found in a randomized trial with overweight patients (n = 49) assessing the contribution
of PE to cardiovascular risk markers (18 in total), showing that this contribution may be inter-subject
dependent or may respond to the baseline characteristics of subjects [59]. Thus, pomegranate extracts
with standardized punicalagins, such as the extract used in this study or PE clustered with specific
ellagitannin metabolites may behave differently. Future clinical trials on isolated active ingredients
(such as punicalagins) would elucidate the specific metabolic and biochemical pathways taking place,
which will be of great value for subsequent future research lines regarding exercise performance
and health.
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4.5. Strength Assessment and Force Restoration
PE was effective improving the recovery of force after an exercise induced muscle damage
provoked by an eccentric exercise protocol in the upper body of recreationally active [60] and
resistance-trained males [60]. However, this was equivocal for lower body isometric unilateral knee
extension 2 h post-eccentric exercise [61] or 4 days after eccentric protocol [62], showing significant
differences in the latter but not the former study. To our knowledge, the current study is the first to
use an isokinetic (instead of isometric) unilateral strength protocol on lower limb muscles after an
eccentric drill. The reason behind the non-significant results found in the current study could be due
to sample size, which, for the previously mentioned study, reached significance with a population of
n = 45 [62] but not in the one with n = 17 [61] or in the current study (n = 26). The only study found
which employed an isokinetic test with pomegranate ellagitannins used a mix of ingredients in which
these polyphenols represented a small portion of the beverage employed [63]. Thus, comparisons
between the latter and the current study should not be made.
4.6. Post-Exercise Recovery
Previous work suggested that polyphenols prevent a rise in the muscular damage biomarker CK
in a cycling test of same characteristics as the first endurance bout in the current study (SWEET, 90 min
at 70% of VO2max) [64] which seems to have been effectively cancelled in the current study, by the
eccentric drill design. A study found that pomegranate supplementation helped in restoring baseline
values of both CK and CRP after weight lifting [65] which was not the case for trained cyclists after
17 days of supplementation with polyphenols [66]. In the current study, baseline values were almost
restored after 72 h without conclusive results of PE’s contribution compared to PLA. Further research
should be conducted to uncover more findings in this field.
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